[A case of rocuronium-induced anaphylactic shock, improved by sugammadex].
CHU Nord, Amiens, France. badaoui.rachid@chu-amiens.fr
Rachid
R
Badaoui
Ivan
I
Popov
Hervé
H
Dupont
D000707:Anaphylaxis / Q000139:chemically induced* / Q000188:drug therapy; D000732:Androstanols / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000077123:Rocuronium; D000077122:Sugammadex; D047408:gamma-Cyclodextrins / Q000627:therapeutic use*
D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D000077123:Rocuronium